Front Street Capital Management Inc. Has $64.79 Million Stock Position in Cognex Corporation $CGNX

Front Street Capital Management Inc. increased its stake in shares of Cognex Corporation (NASDAQ:CGNX) by 1.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,322,588 shares of the scientific and technical instruments company’s stock after buying an additional 13,293 shares during the quarter. Cognex comprises approximately 8.4% of Front Street Capital Management Inc.’s holdings, making the stock its 2nd largest position. Front Street Capital Management Inc.’s holdings in Cognex were worth $64,794,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in CGNX. Geneos Wealth Management Inc. grew its holdings in Cognex by 402.2% in the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after buying an additional 736 shares in the last quarter. CIBC Private Wealth Group LLC boosted its position in Cognex by 74.8% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock worth $35,000 after acquiring an additional 327 shares during the period. Cassaday & Co Wealth Management LLC bought a new position in shares of Cognex in the first quarter worth $36,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Cognex during the fourth quarter valued at $39,000. Finally, Larson Financial Group LLC increased its holdings in shares of Cognex by 202.7% during the fourth quarter. Larson Financial Group LLC now owns 1,105 shares of the scientific and technical instruments company’s stock valued at $40,000 after purchasing an additional 740 shares during the period. Institutional investors and hedge funds own 88.12% of the company’s stock.

Insider Activity

In related news, VP Darren Marc Long sold 20,252 shares of the stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $66.34, for a total value of $1,343,517.68. Following the completion of the transaction, the vice president owned 3,990 shares in the company, valued at $264,696.60. This trade represents a 83.54% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, VP Laura Ann Macdonald sold 41,600 shares of Cognex stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $65.56, for a total value of $2,727,296.00. Following the completion of the transaction, the vice president directly owned 5,258 shares in the company, valued at $344,714.48. This represents a 88.78% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 224,847 shares of company stock valued at $14,975,098 over the last three months. Insiders own 1.70% of the company’s stock.

Cognex Stock Performance

Shares of NASDAQ:CGNX opened at $62.62 on Friday. The stock has a market capitalization of $10.42 billion, a price-to-earnings ratio of 74.55 and a beta of 1.49. Cognex Corporation has a 1-year low of $34.60 and a 1-year high of $72.88. The company has a 50 day moving average price of $64.81 and a 200 day moving average price of $56.09.

Cognex (NASDAQ:CGNX) last posted its quarterly earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.09. Cognex had a return on equity of 10.89% and a net margin of 13.62%.The company had revenue of $268.44 million for the quarter, compared to analysts’ expectations of $245.98 million. During the same quarter in the prior year, the company earned $0.14 earnings per share. The firm’s revenue was up 24.3% on a year-over-year basis. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. On average, sell-side analysts expect that Cognex Corporation will post 1.48 EPS for the current fiscal year.

Cognex Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 4th. Stockholders of record on Thursday, May 21st were given a dividend of $0.085 per share. The ex-dividend date of this dividend was Thursday, May 21st. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.5%. Cognex’s payout ratio is 40.48%.

Wall Street Analysts Forecast Growth

CGNX has been the subject of a number of recent analyst reports. Truist Financial increased their target price on shares of Cognex from $61.00 to $71.00 and gave the company a “hold” rating in a research report on Thursday, July 2nd. Weiss Ratings reiterated a “hold (c)” rating on shares of Cognex in a report on Friday, May 15th. Seaport Research Partners set a $75.00 target price on Cognex in a report on Tuesday, May 26th. JPMorgan Chase & Co. upgraded Cognex from a “neutral” rating to an “overweight” rating and upped their target price for the stock from $65.00 to $75.00 in a research report on Tuesday, May 26th. Finally, UBS Group set a $75.00 price objective on Cognex in a research note on Tuesday, May 26th. Two investment analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $72.31.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.